PharmExec Direct: Having trouble viewing the email? Click Here

In this ISSUE

Pharm Exec's Emerging Eleven: Slide Show

Challenges for Early Entrants in the NASH Market

NASH: Pointers for Pharma from the Patient Perspective

Advertisement
Top Feature
Pharm Exec's Emerging Pharma Leaders 2017
Pharm Exec's 10th annual list of rising leaders highlights 11 pharma managers who are poised to help chart the industry's path forward
/Read more/
Advertisement
The 2017 Sharing Conference: Compliance • Transparency • PDMA • OIG
Join your peers at the premier learning and sharing event for Pharmaceutical, Medical Device and Biotech Compliance Professionals. In general sessions, workshops, open forums, speed sessions and in our exhibit hall, the Sharing Conference offers attendees 3 days of complete immersion in a wide variety of compliance subjects. The 2017 Sharing Conference is being held 10/22 – 10/24 at the Baltimore Marriott Waterfront. Learn more by visiting
Direct-to-Consumer
FDA Considers More Targeted Risk Information in DTC Ads
FDA is evaluating whether limiting warnings in TV commercials to the most serious adverse effects might be more informative for consumers than the current laundry lists of potential side effects. Jill Wechsler reports
/Read more/
Calendar
/ October 24–25: 12th Annual Value-Based Oncology Management /
Scottsdale, AZ
/ October 26–27: MedComm /
San Francisco, CA
/ 14 November: EU GDPR Bootcamp Life Sciences /
London, UK
/ November 15-16: 4th Annual Global Compliance Congress for Life Sciences /
London, UK
/ November 28–29: Commercial Data Insights /
Philadelphia, PA
/ December 4–5: Connected Devices in Healthcare /
San Diego, CA
/ February 7–8, 2018: Speaker Programs 2018 /
Philadelphia, PA
/ March 25–28, 2018: 14th Annual Pharma Forum /
Philadelphia, PA
Advertisement
Advertisement
Value-Based Strategies for Reimbursement and Formulary Success
ExL’s first annual Value-Based Strategies for Reimbursement and Formulary Success Event is taking place on November 6-7 in Bethesda MD. This event will pioneer the conversation of the transition from price-centric to value-based formularies. Life science and healthcare insurance executives will provide attendees with education in proving value, instead of managing pricing of drugs coming onto the market. Learn more
Digital Pharma
Rebooting Life Sciences with Digital
Bhaskar Sambasivan offers a prescription for thriving in the new digital economy
/Read more/
Advertisement
Launching into Value: Pharma’s Quest to Align Drug Prices with Outcomes
On Demand
Learn more
Interview
TESARO: Setting New Benchmarks in Patient-Centricity
Mary Lynne Hedley, President and COO of oncology company TESARO, talks about responsible drug development and commercialization, and the practical dimension of putting patients first
/Read more/
Advertisement
How Can Scientific Dissemination Data Help Medical Affairs Adopt a more Strategic Role?
On Demand
Learn more
Industry update
//Tetraphase Pharmaceuticals (Watertown, MA) announced the appointment of Kamalam (Kam) Unninayar as Chief Financial Officer. //Histogenics Corporation (Watertown, MA) promoted Stephen Kennedy from Chief Technology Officer to Executive Vice President & Chief Operating Officer. //Inception Companies (Fairfield, NJ) hired Matt Giegerich, longtime CEO of WPP's Ogilvy CommonHealth to serve as CEO for its two lead businesses, Inception Digital and Kampfire. //Envigo (Princeton, NJ) appointed Dr. Naheed Rehman as new business lead consultant, chemicals.
Advertisement
Accelerate Real World Evidence: Leveraging Data for Faster Time to Insight
On Demand
Learn more
 
advertise with us / print subscribe / digital subscribe / visit pharmexec.com